Skip to content
peptide

KPV

moderateResearch Use OnlyOralInjection

Three-amino-acid anti-inflammatory peptide especially effective for gut inflammation. Go-to for IBD and inflammatory gut issues. Also calms systemic inflammation.


Key facts
Classification
KPV is an α-MSH-derived tripeptide retaining anti-inflammatory properties without melanotropic activity.
Primary benefits
Gut Health (9/10) · Inflammation (9/10) · Immune Support (4/10)
Administration
Oral, Injection
Doses studied
200-500 mcg oral or subq daily. Take it by mouth if you're targeting the gut specifically. Cycle for 4-8 weeks.
Evidence strength
Moderate — 20 peer-reviewed studies
Stacks well with
BPC-157, LL-37, Thymosin Alpha-1, Larazotide Acetate
Legal status
Research Use Only · not prescribable in US
Quick stats
Type
Peptide
Administration
Oral, Injection
Studies referenced
20
Stacks with
4 peptides
Regulatory
Research Use Only
Scientific overview

KPV is an α-MSH-derived tripeptide retaining anti-inflammatory properties without melanotropic activity. Inhibits NF-κB nuclear translocation and reduces IL-1β, IL-6, and TNF-α. Demonstrated efficacy in IBD models by reducing mucosal inflammation and promoting epithelial barrier integrity.

Goal coverage · KPV
🫃 Gut Health9/10
🧊 Inflammation9/10
🛡️ Immune Support4/10
Skin & Hair3/10
FIG.1  Modeled goal coverage from reviewed studies. Score out of 10.
Medical oversight recommendedNot safe during pregnancy· 2 contraindications
From our network:Cornerstone Peptide